Introduction
Type 2 diabetes and hypothyroidism are two major public health issues, affecting ~9% and 2%, respectively, of the population worldwide [
1,
2]. These endocrine pathologies alter whole body metabolism and can sometimes be related, without presenting a common aetiology [
3,
4]. Type 2 diabetes arises from a complex interplay between genetic and environmental factors [
5]. In particular, the fetal environment plays a key role in the establishment of a functional beta cell mass [
6]. Changes in the intrauterine milieu can modify beta cell differentiation and proliferation in the fetus, leading to long-term effects on glucose metabolism [
7].
Different maternal conditions alter circulating concentrations of nutrients and hormones, which might impact beta cell development in utero. First, pre-existing metabolic disorders, such as malnutrition, obesity and diabetes, have been linked to increased susceptibility of the offspring to chronic diseases, such as hypertension and diabetes [
7,
8]. In mice, maternal diabetes induces fetal hyperglycaemia and hyperinsulinaemia through accelerated endocrine pancreas development, predisposing to type 2 diabetes at later stages [
9]. Second, gestation itself leads to important metabolic and hormonal modifications. For instance, gestational diabetes, occurring in 13% of pregnancies [
10], alters endocrine pancreas maturation in the fetus and constitutes a risk factor for type 2 diabetes in adulthood [
9]. In addition, gestation increases demand on thyroid hormones in the mother, leading to hypothyroidism in 0.5% of pregnancies [
11].
As master metabolic gatekeepers, the thyroid hormones thyroxine (3,3′,5,5′ tetraiodothyronine; T
4) and 3,3′,5-triiodothyronine (T
3) play an essential role in metabolism and fetal development. Maternal hypothyroidism is associated with deficits in fetal growth and cardiac, nervous and bone maturation [
12,
13]. Such dramatic effects result from a complete dependence of the fetus on maternal thyroid hormones until mid-gestation in mice and second trimester of pregnancy in humans [
14,
15], and a continued influence of maternal thyroid hormones at later stages [
14]. At the level of the pancreas, different studies have demonstrated important effects of thyroid hormones on beta cell development and maturation [
16,
17]. These effects can be direct, through specific interactions with cognate receptors on beta cells [
18], or indirect, through modification of the availability of growth factors [
16], thereby altering glucose metabolism and insulin resistance [
3]. Although a recent study showed that fetal hypothyroidism in sheep leads to increased beta cell proliferation and hyperinsulinaemia in the fetus [
17], the consequences of gestational hypothyroidism on beta cell function in adult offspring remains unexplored. Thus, we sought to investigate the effects of gestational hypothyroidism on beta cell maturity and function, glucose metabolism, and susceptibility to metabolic stress such as high-fat diet (HFD) in adult mouse offspring and their descendants.
Discussion
Circulating factors in utero can influence fetal endocrine pancreas development and lead to life-long alterations in glucose metabolism. Since gestation modulates thyroid hormone concentrations, which are known to play an important role in beta cell development and maturation [
12,
17], we sought to investigate whether maternal hypothyroidism influences glucose homeostasis in adult offspring. We found that gestational hypothyroidism increased beta cell proliferation, altered glucose metabolism and increased the severity of HFD-induced obesity in offspring, without altering beta cell maturity and functional responses. Furthermore, alterations in glucose metabolism were maintained in a second generation of adults. These results therefore indicate that maternal hypothyroidism may exert transgenerational effects on glucose homeostasis, although primary effects on germ cells during the previous pregnancy cannot be completely excluded.
Hypothyroidism is one of the most common endocrine diseases during pregnancy and is mainly linked to dietary iodine deficiency, especially in low–middle income countries [
3]. Thus, iodine deficiency in the diet constitutes a robust model to induce congenital hypothyroidism through decreases in circulating total T
4 concentration during gestation [
26]. While definitive confirmation of hypothyroidism would also require measurement of thyroid-stimulating hormone (TSH), commercial assay kits do not work reliably in mice. Exposure to hypothyroidism in utero has been reported to influence growth in other rodents [
28,
29]. However, we could not detect significant differences in body mass between mice born to euthyroid or hypothyroid mothers. While this may reflect the model used, we note that intrauterine growth restriction does not necessarily correlate with altered body weights in neonates [
30]. Indeed, in sheep, hypothyroidism in utero induced pancreatic beta cell proliferation and hyperinsulinaemia in the fetus [
17], which would be expected to maintain growth rate.
Although the effects of thyroid hormone deficiency on fetal pancreas development were not assessed here, congenital hypothyroidism in mice altered glucose metabolism and stimulated beta cell proliferation in both adult male and female mouse offspring. This suggests impaired development of the fetal or postnatal pancreas, leading to long-term changes in glucose metabolism [
31]. However, whether these long-term changes persist for the lifespan of the animal remains to be investigated. Interestingly, beta cell proliferation was not accompanied by an increase in islet size or beta cell mass or a clear shift in islet size range. This may be due to timing of analysis or relative sensitivies of beta cell proliferation vs islet size measures. In addition, we cannot exclude the possibility that proliferation is balanced by apoptosis or cell cycle progression block after mitosis, maintaining beta cell mass. This, however, remains to be investigated. Overall, the alterations were more pronounced in male offspring, possibly reflecting known sex-dependent effects of fetal hypothyroidism on glucose metabolism [
32] and pointing to the importance of including both sexes in studies of this type. In fact, T
4-dependent liver function and metabolism is sex-dependent, and sex is an important modifier of the extent of phenotypic manifestations of hypo- or hyperthyroidism, not only at the metabolic level, but also of functional, biochemical and molecular traits [
33].
In line with our results, congenital hypothyroidism has been previously shown to induce long-term alterations in glucose metabolism in adult male rat offspring [
31,
34]. In particular, insulin secretion was found to be decreased, in contrast to the lack of difference detected in the present study. The reasons for this are unknown, but may include the dynamic evolution of glucose metabolism with age (young adult vs mature animals), the proliferative status of beta cells (not assessed in rat studies), and/or species-related differences.
Since glucose-stimulated Ca
2+ fluxes are a major triggering signal for insulin release [
35], we hypothesised that long-term alterations in glucose metabolism induced by congenital hypothyroidism may be linked to changes in beta cell stimulus–secretion coupling. Previous studies on isolated islets from male rat offspring showed that maternal hypothyroidism led to impaired insulin secretion through a combination of different mechanisms, including alteration in glycolytic pathways and ATP sensitive K
+ (K
ATP) and L-type Ca
2+ channel conductance [
34]. However, both glucose- and KCl-induced Ca
2+ rises were found to be unchanged in islets from male animals born to hypothyroid mothers. Thus, the changes in in vivo insulin responses and glucose metabolism described in the present study are likely to result from mechanisms distal to Ca
2+ fluxes, such as amplyfying pathway (e.g. cAMP) or granule exocytosis. Alternatively, since thyroid hormones are crucial regulators of growth, development and metabolism in virtually all tissues, in particular during fetal stages [
12], metabolic alterations may rise from a combination of modifications in different organs. For instance, congenital hypothyroidism has been shown to alter liver development [
36], and modify glucose transporter expression, impairing glucose sensing in glucose-sensitive organs, including the liver and metabolic regions of the brain [
37]. Further studies will be needed to explore both these possibilities.
In adults, beta cell proliferation is triggered in response to increased metabolic demand such as gestation and HFD feeding [
27,
38]. Although triiodothyronine stimulates proliferation of rat beta cell lines [
39], whether thyroid hormones contribute to beta cell proliferation in response to demand remains unclear. During fetal development, the prepartum surge in thyroid hormone is thought to induce a switch from beta cell proliferation to functional maturation [
16,
40], thus explaining the maintenance of beta cell proliferation in islets of hypothyroid sheep fetuses [
17]. It is likely that similar mechanisms are at play in offspring of hypothyroid mothers, although we cannot exclude an increase in beta cell proliferation due to increased metabolic demand and/or insulin resistance. The source of such increased demand is, however, unclear, especially since ND-fed offspring displayed increase insulin sensitivity. Since T
3/T
4 are pre-requisite for cell maturation [
41], and because in vivo insulin responses to glucose were decreased, we analysed overall gene expression of key markers defining adult beta cell functional identity [
42]. However, we could not detect major changes in adult offspring from hypothyroid mothers, in line with the Ca
2+ imaging data, suggesting that beta cell de-differentiation/or lack of maturation is not a feature here.
In addition to altered glucose metabolism and increased beta cell proliferation, maternal hypothyroidism increased susceptibility to HFD-induced metabolic stress in adult male offspring. Although glucose tolerance was not measured by dosing glucose according to lean body mass, differences are likely to persist, given the profound effect on all metabolic variables. This result fits with previous data showing that environmental alterations during endocrine pancreas development can induce long-term consequences for glucose metabolism [
7]. The results here support the notion that maternal hypothyroidism may increase risk of type 2 diabetes development in later life. This increased susceptibility may be linked to exacerbated HFD-induced hyperinsulinaemia, which has previously been shown to drive insulin resistance and diet-induced obesity [
43]. Again, changes were independent of Ca
2+ channel activity, suggesting that the insulin secretory defect may lie distal to the triggering pathway. Although female offspring were not analysed, similar results would be expected, since congenital hypothyroidism also affected glucose metabolism in female offspring. Suggesting the presence of normal thyroid function in neonates born to hypothyroid mothers, total T
4 concentrations were similar to control animals born to euthyroid mothers. Thus, effects of reduced maternal T
4 on pancreas development might be either indirect, through altered placental size or function, for instance, or direct during early development, while the fetus is entirely dependent on maternal T
4 hormone. This, however, remains to be investigated. Notably, maternal hyperglycaemia has also been shown to result in altered glucose metabolism in the progeny and increased predisposition to diabetes [
44]. Since hypothyroidism affects glucose metabolism and insulin resistance [
45], the extent to which alterations in maternal glucose homeostasis might account for some of the findings remains to be deciphered.
Finally, we saw that altered glucose metabolism persisted in a second generation of offspring, albeit to a lesser extent, suggesting the presence of epigenetic changes. Such changes are likely to be imprinted as a result of thyroid hormone deprivation during fetal development, since epigenetic reprogramming occurs during gametogenesis and early embryogenesis [
46], before being transmitted to the next generation. It has indeed been shown in other models of nutritional insult in pregnant mice (e.g. high-fat, methyl-deficient or low-protein diets) that induction of epigenetic marks in beta cells leads to altered function and diabetes risk later in life [
47,
48]. These epigenetic changes might be in part mediated through changes in maternal thyroid hormone secretion, since nutritional status is an important regulator of thyroid activity [
49]. In addition, since both liver and pancreas are affected by similar signalling pathways during development and both organs display remarkable plasticity following insult in adults, epigenetic markers are likely to affect other organs than the endocrine pancreas [
50]. We concede, however, that identification of these epigenetic markers is needed, and that a multitude of other mechanisms at central and peripheral levels may also be involved in altered glucose homeostasis following changes in thyroid hormone concentrations. A multi-organ analysis is warranted to achieve a full understanding of the effects.
In summary, we show that gestational hypothyroidism induces transgenerational effects on glucose metabolism in the offspring, which may affect predisposition to type 2 diabetes development in response to metabolic stress.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.